Title and authors | Publication | Year |
---|---|---|
Putative roles of purinergic signaling in human immunodeficiency virus-1 infection
PA Pacheco, RX Faria, LG Ferreira, IC Paixão |
Biology direct | 2014 |
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort
AM Cescon, C Cooper, K Chan, AK Palmer, MB Klein, N Machouf, MR Loutfy, J Raboud, A Rachlis, E Ding, VD Lima, JS Montaner, SB Rourke, M Smieja, C Tsoukas, RS Hogg |
HIV Medicine | 2010 |
Effect of Antiretroviral Therapy on Apoptosis Markers and Morphology in Peripheral Lymph Nodes of HIV-Infected Individuals
S Ehrhard, M Wernli, G Kaufmann, G Pantaleo, GP Rizzardi, F Gudat, P Erb, M Battegay |
Infection | 2008 |
Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques:
L Kinman, SJ Brodie, CC Tsai, T Bui, K Larsen, A Schmidt, D Anderson, WR Morton, SL Hu, RJ Ho |
Journal of acquired immune deficiency syndromes (1999) | 2003 |
Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors
SJ Hurwitz, RF Schinazi |
Antiviral Research | 2002 |
Emerging viral infections
LM Lee, DK Henderson |
Current Opinion in Infectious Diseases | 2001 |
Medical Immunology, Fifth Edition
G Virella, JM Goust |
Medical Immunology, Fifth Edition | 2001 |
Hit HIV-1 hard, but only when necessary
M Harrington, CC Carpenter |
The Lancet | 2000 |